Beyond DNA Repair: DNA-PK Function in Cancer

被引:193
|
作者
Goodwin, Jonathan F. [1 ]
Knudsen, Karen E. [1 ,2 ,3 ,4 ]
机构
[1] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
关键词
DEPENDENT-PROTEIN-KINASE; DOUBLE-STRAND BREAKS; RNA-POLYMERASE-II; ATAXIA-TELANGIECTASIA GENE; HUMAN GLIOBLASTOMA CELLS; ESTROGEN-RECEPTOR-ALPHA; HUMAN TUMOR-CELLS; CATALYTIC-SUBUNIT; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION;
D O I
10.1158/2159-8290.CD-14-0358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The DNA-dependent protein kinase (DNA-PK) is a pivotal component of the DNA repair machinery that governs the response to DNA damage, serving to maintain genome integrity. However, the DNA-PK kinase component was initially isolated with transcriptional complexes, and recent findings have illuminated the impact of DNA-PK-mediated transcriptional regulation on tumor progression and therapeutic response. DNA-PK expression has also been correlated with poor outcome in selected tumor types, further underscoring the importance of understanding its role in disease. Herein, the molecular and cellular consequences of DNA-PK are considered, with an eye toward discerning the rationale for therapeutic targeting of DNA-PK. Significance: Although DNA-PK is classically considered a component of damage response, recent findings illuminate damage-independent functions of DNA-PK that affect multiple tumor-associated pathways and provide a rationale for the development of novel therapeutic strategies. (C) 2014 AACR.
引用
收藏
页码:1126 / 1139
页数:14
相关论文
共 50 条
  • [1] Emerging roles of DNA-PK besides DNA repair
    Kong, Xianming
    Shen, Ying
    Jiang, Na
    Fei, Xin
    Mi, Jun
    CELLULAR SIGNALLING, 2011, 23 (08) : 1273 - 1280
  • [2] Small molecules, inhibitors of DNA-PK, targeting DNA repair, and beyond
    Davidson, David
    Amrein, Lilian
    Panasci, Lawrence
    Aloyz, Raquel
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [3] Targeting DNA-PK in cancer
    Damia, Giovanna
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2020, 821
  • [4] DNA-PK: A dynamic enzyme in a versatile DSB repair pathway
    Davis, Anthony J.
    Chen, Benjamin P. C.
    Chen, David J.
    DNA REPAIR, 2014, 17 : 21 - 29
  • [5] DNA-PK: A synopsis beyond synapsis
    Goff, Noah J.
    Mikhova, Mariia
    Schmidt, Jens C.
    Meek, Katheryn
    DNA REPAIR, 2024, 141
  • [6] DNA-PK as an Emerging Therapeutic Target in Cancer
    Mohiuddin, Ismail S.
    Kang, Min H.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [7] ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
    Blackford, Andrew N.
    Jackson, Stephen P.
    MOLECULAR CELL, 2017, 66 (06) : 801 - 817
  • [8] Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK
    Das, Benu Brata
    Antony, Smitha
    Gupta, Shalu
    Dexheimer, Thomas S.
    Redon, Christophe E.
    Garfield, Susan
    Shiloh, Yosef
    Pommier, Yves
    EMBO JOURNAL, 2009, 28 (23) : 3667 - 3680
  • [9] Visualization of a DNA-PK/PARP1 complex
    Spagnolo, Laura
    Barbeau, Jody
    Curtin, Nicola J.
    Morris, Edward P.
    Pearl, Laurence H.
    NUCLEIC ACIDS RESEARCH, 2012, 40 (09) : 4168 - 4177
  • [10] Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics
    Sharma, Ram
    Mishra, Anshul
    Bhardwaj, Monika
    Singh, Gurpreet
    Harahap, Larasati Vanya Indira
    Vanjani, Sakshi
    Pan, Chun Hsu
    Nepali, Kunal
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)